Movement Disorders

The professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.

From post-implantation screening to 3 months, those in the active treatment arm reported a mean improvement of 3.03 more hours of on time than the control group with Boston Scientific’s deep brain stimulation device.

Neurology News Network for the week ending May 30, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 29, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 22, 2020.

The drug is the first on-demand off episode treatment to be administered sublingually.

The data support the need to raise awareness of involuntary movements from possible tardive dyskinesia and the importance of properly screening and diagnosing patients.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 15, 2020.

Automated Imaging Differentiation in Parkinsonism (AID-P) outperformed both the Magnetic Resonance Parkinsonism Index and neurofilament light chain protein in differentiating PD from atypical parkinsonism.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 8, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 1, 2020.

The COMT inhibitor helps increase ON time without promoting dyskinesia.